1 year return (CAGR)
-41.75%
Qualigen Therapeutics Inc Exchange (NASDAQ, USD)
QLGN
-
+0.01 (+0.30%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-67.68%
5 year return (CAGR)
-73.57%
10 year return (CAGR)
-67.39%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.74M
Price/Sales
2.12
Ent value
-29.12M
Price/Book
0.12
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-11.18%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-24.89%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 2.33 |
| Daily high | 2.37 |
| Daily low | 2.30 |
| Daily Volume | 76K |
| 1y analyst estimate | 5.00 |
| Beta | 0.28 |
| EPS (TTM) | -3.23 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| QLGN | S&P500 | |
| Current price drop from All-time high | -100.00% | -2.53% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 16 Sep 2025 | 9 Mar 2009 |
| Avg drop from high | -90.72% | -10.69% |
| Avg time to new high | 1330 days | 12 days |
| Max time to new high | 2658 days | 1805 days |
News
No items found